Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.
about
Interferon lambda: a new sword in cancer immunotherapyInterferon-λ: Immune Functions at Barrier Surfaces and BeyondInterferon-lambdas: the modulators of antivirus, antitumor, and immune responsesModulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokinesMapping quantitative trait loci for T lymphocyte subpopulations in peripheral blood in swine.Interferon-λ in HCV Infection and Therapy.Genetic variations in IL28B and allergic disease in children.IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9IL-28B is a key regulator of B- and T-cell vaccine responses against influenzaIL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.Interferon lambdas: the next cytokine stormMinireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathologyInterferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activityInterleukin-29 modulates proinflammatory cytokine production in synovial inflammation of rheumatoid arthritis.Activation of toll-like receptor-3 induces interferon-lambda expression in human neuronal cells.Impact of host genetic polymorphisms on vaccine induced antibody responseType III Interferons in Hepatitis C Virus Infection.Interferon Lambda: Modulating Immunity in Infectious Diseases.IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.IL28B and the control of hepatitis C virus infection.Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells.IFN-λ and IgE-mediated allergic disease: a potential future role?The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation.Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.IL-29 Enhances CXCL10 Production in TNF-α-stimulated Human Oral Epithelial Cells.Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses.Targeting IFN-λ: therapeutic implications.A functional IFN-λ4-generating DNA polymorphism could protect older asthmatic women from aeroallergen sensitization and associate with clinical features of asthmaIL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease.Serum IFN-λ1 is abnormally elevated in rheumatoid arthritis patients.Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29).Elevated Systemic and Parasite-Antigen Stimulated Levels of Type III IFNs in a Chronic Helminth Infection and Reversal Following Anthelmintic Treatment
P2860
Q21296797-17918391-C88F-46D6-BF35-A1C602E4A032Q26801049-AAF34683-AB5B-48FF-98AB-C5E5CD8BAAC1Q28238963-4DEF092C-3A43-4916-BD41-1CB88015B08EQ28258808-C00A58C9-B12F-4DC0-B883-729E76873766Q28260203-7F1091B1-E0EB-4852-8BBF-AF5FBB3AEC06Q34020900-E0518935-8C86-4266-AA04-A32BFD4D8A22Q34047500-BECC98EC-9B90-4E7C-8779-229183D89BC0Q34147621-0BF52A32-2170-43FC-BD56-B96200CDE778Q34147632-51A688F6-DA1A-4044-BFC3-4F776D8883CAQ34305671-B42716DD-3DD5-44FC-9726-F4419C45DB44Q34682206-21E4EBCB-BE80-448B-8082-69623F1B9617Q35042843-92294810-1D2A-4633-83A4-6843FD2C6882Q35154826-6A0B03E1-64F2-4221-827D-0108462184A3Q35507942-2BD8A90C-F9B4-4AB7-80ED-E954B8080334Q35557898-DB17D50D-30EA-4B8C-8BC6-768960B66BC6Q36633252-614EEC5D-D2C8-46CD-BEDC-008748148DD6Q37116204-A0AD96EA-FD43-4821-9451-F2507E452CB6Q37130716-8EF72197-E150-4FC8-9585-9F0666BC9AB3Q37528605-F3E2DAC6-DC3B-42D2-8214-BB76769A4350Q37670446-C0387B1B-609B-4EB3-B0CB-F20BD13A6F80Q37690200-CCA8E013-5ED1-4D4F-A7AE-B43D280B78DEQ37800518-87ADDDDD-00E5-4D7A-A750-282CD07B93DFQ37845585-13F1D91C-05AF-42C3-B5DD-2BA73345E320Q37997043-3F608E3C-E6C9-4061-814B-55F420FA5607Q38514365-45D689D7-3B3D-4B99-8D65-C2E8A2E605C2Q38535876-57664139-71C6-40E7-874F-0687DABF1BC7Q38623190-208EE10A-9BD0-4C2A-9EF4-312426FD8007Q38696203-7EE6AC9F-6741-4F45-8BAA-92B90C6A7E11Q38780088-7B0320AE-C486-4F99-9BDB-3193EB5CB772Q38816811-52E1BA0B-3A19-4BD6-9643-577B7131A5E6Q41621173-303626C5-1078-426F-8D77-5EC2EFB94A0BQ41863615-B1435673-B5AC-489A-A411-1D799B2A4645Q46121871-C7AC0495-8083-4818-A4B8-CD998180D996Q53474166-E981DDAA-8DF0-4639-AFF6-8D8F9604E22BQ58572718-117EEA03-3284-42DE-9924-95AD690C06F0
P2860
Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Interferon-lambda1 (interleuki ...... 2 cytokine responses in vitro.
@en
Interferon-lambda1
@nl
type
label
Interferon-lambda1 (interleuki ...... 2 cytokine responses in vitro.
@en
Interferon-lambda1
@nl
prefLabel
Interferon-lambda1 (interleuki ...... 2 cytokine responses in vitro.
@en
Interferon-lambda1
@nl
P2093
P2860
P1433
P1476
Interferon-lambda1 (interleuki ...... 2 cytokine responses in vitro.
@en
P2093
Grant E Gallagher
Grant Gallagher
Jihong Dai
Joyce Eskdale
Nicholas J Megjugorac
Shekar Srinivas
P2860
P304
P356
10.1111/J.1365-2567.2008.02862.X
P577
2008-06-10T00:00:00Z